EU/1/13/907/020 |
6506B |
Adempas 2,5 mg filmom obalené tablety |
tbl flm 294x2,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/019 |
6505B |
Adempas 2 mg filmom obalené tablety |
tbl flm 294x2 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/018 |
6504B |
Adempas 1,5 mg filmom obalené tablety |
tbl flm 294x1,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/017 |
6503B |
Adempas 1 mg filmom obalené tablety |
tbl flm 294x1 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/016 |
6502B |
Adempas 0,5 mg filmom obalené tablety |
tbl flm 294x0,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/015 |
9761A |
Adempas 2,5 mg filmom obalené tablety |
tbl flm 90x2,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/014 |
9760A |
Adempas 2,5 mg filmom obalené tablety |
tbl flm 84x2,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/013 |
9759A |
Adempas 2,5 mg filmom obalené tablety |
tbl flm 42x2,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/012 |
9758A |
Adempas 2 mg filmom obalené tablety |
tbl flm 90x2 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/011 |
9757A |
Adempas 2 mg filmom obalené tablety |
tbl flm 84x2 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/010 |
9756A |
Adempas 2 mg filmom obalené tablety |
tbl flm 42x2 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/009 |
9755A |
Adempas 1,5 mg filmom obalené tablety |
tbl flm 90x1,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/008 |
9754A |
Adempas 1,5 mg filmom obalené tablety |
tbl flm 84x1,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/007 |
9753A |
Adempas 1,5 mg filmom obalené tablety |
tbl flm 42x1,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/006 |
9752A |
Adempas 1 mg filmom obalené tablety |
tbl flm 90x1 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/005 |
9751A |
Adempas 1 mg filmom obalené tablety |
tbl flm 84x1 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/004 |
9750A |
Adempas 1 mg filmom obalené tablety |
tbl flm 42x1 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/003 |
9749A |
Adempas 0,5 mg filmom obalené tablety |
tbl flm 90x0,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/002 |
9748A |
Adempas 0,5 mg filmom obalené tablety |
tbl flm 84x0,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/13/907/001 |
9747A |
Adempas 0,5 mg filmom obalené tablety |
tbl flm 42x0,5 mg (blis.PP/Al) |
BAY |
27.03.2019 |
EU/1/06/342/001 |
36227 |
Nexavar 200 mg filmom obalené tablety |
tbl flm 112x200 mg (blis.PP/Al) |
BAY |
|
EU/1/14/979/004 |
3085B |
Ofev 150 mg mäkké kapsuly |
cps mol 60x1x150 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
EU/1/14/979/003 |
3084B |
Ofev 150 mg mäkké kapsuly |
cps mol 30x1x150 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
EU/1/14/979/002 |
3083B |
Ofev 100 mg mäkké kapsuly |
cps mol 60x1x100 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
EU/1/14/979/001 |
3082B |
Ofev 100 mg mäkké kapsuly |
cps mol 30x1x100 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
EU/1/14/987/001 |
3265B |
Holoclar 79 000 - 316 000 buniek/cm2 transplantát |
tra 1x3,8 cm2 (nádoba- nehrdz.oce?) |
CHS |
19.02.2019 |
EU/1/17/1258/003 |
7606C |
Lamzede 10 mg prášok na infúzny roztok |
plv ifo 10x10 mg (liek.inj.skl.) |
CHS |
23.03.2023 |
EU/1/17/1258/002 |
7605C |
Lamzede 10 mg prášok na infúzny roztok |
plv ifo 5x10 mg (liek.inj.skl.) |
CHS |
23.03.2023 |
EU/1/17/1258/001 |
7604C |
Lamzede 10 mg prášok na infúzny roztok |
plv ifo 1x10 mg (liek.inj.skl.) |
CHS |
23.03.2023 |
EU/1/13/861/002 |
7046A |
PROCYSBI 75 mg tvrdé gastrorezistentné kapsuly |
cps end 250x75 mg (f?.HDPE) |
CHS |
|
EU/1/13/861/001 |
7045A |
PROCYSBI 25 mg tvrdé gastrorezistentné kapsuly |
cps end 60x25 mg (f?.HDPE) |
CHS |
|
EU/1/09/528/002 |
07849 |
Peyona 20 mg/ml infúzny intravenózny roztok a perorálny roztok |
sol ipr 10x1 ml/20 mg (amp.skl.) |
CHS |
|
EU/1/09/528/001 |
78430 |
Peyona 20 mg/ml infúzny intravenózny roztok a perorálny roztok |
sol ipr 10x3 ml/60 mg (amp.skl.) |
CHS |
|
EU/1/17/1254/005 |
6909C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 100x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/004 |
6908C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 90x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/003 |
6907C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 60x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/002 |
6906C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 30x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/001 |
6905C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 20x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/14/974/003 |
3782B |
Cerdelga 84 mg tvrdé kapsuly |
cps dur 14x84 mg (blis.PETG/COC.PETG/PCTFE-Al) |
GZE |
19.01.2020 |
EU/1/14/974/002 |
2877B |
Cerdelga 84 mg tvrdé kapsuly |
cps dur 196x84 mg (blis.PETG/COC.PETG/PCTFE-Al) |
GZE |
19.01.2020 |
EU/1/14/974/001 |
2876B |
Cerdelga 84 mg tvrdé kapsuly |
cps dur 56x84 mg (blis.PETG/COC.PETG/PCTFE-Al) |
GZE |
19.01.2020 |
EU/1/09/537/001 |
79106 |
Mozobil 20 mg/ml injek?ný roztok |
sol inj 1x1,2 ml/24 mg ( liek.inj.skl.) |
GZE |
|
EU/1/17/1219/004 |
8476C |
Verkazia 1 mg/ml o?ná emulzná instilácia |
int ope 120x0,3 ml/0,3 mg |
SOY |
06.07.2023 |
EU/1/17/1219/003 |
8475C |
Verkazia 1 mg/ml o?ná emulzná instilácia |
int ope 90x0,3 ml/0,3 mg |
SOY |
06.07.2023 |
EU/1/17/1219/002 |
8474C |
Verkazia 1 mg/ml o?ná emulzná instilácia |
int ope 60x0,3 ml/0,3 mg |
SOY |
06.07.2023 |
EU/1/17/1219/001 |
8473C |
Verkazia 1 mg/ml o?ná emulzná instilácia |
int ope 30x0,3 ml/0,3 mg |
SOY |
06.07.2023 |
EU/1/17/1245/004 |
6846C |
PREVYMIS 480 mg koncentrát na infúzny roztok |
con inf 1x24 ml/480 mg (liek.inj.skl.) |
MSD-NL |
08.01.2023 |
EU/1/17/1245/003 |
6845C |
PREVYMIS 240 mg koncentrát na infúzny roztok |
con inf 1x12 ml/240 mg (liek.inj.skl.) |
MSD-NL |
08.01.2023 |
EU/1/17/1245/002 |
6844C |
PREVYMIS 480 mg filmom obalené tablety |
tbl flm 28x1x480 mg (blis.Al/Al-jednotk.dávka) |
MSD-NL |
08.01.2023 |
EU/1/17/1245/001 |
6843C |
PREVYMIS 240 mg filmom obalené tablety |
tbl flm 28x1x240 mg (blis.Al/Al-jednotk.dávka) |
MSD-NL |
08.01.2023 |